ER+, HER2-, Metastatic Breast Cancer
2 clinical trials · Condition
◉ Watch ER+, HER2-, Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| AZD9833 China PK Study (NCT04818632) | AstraZeneca | 2021-11-12 |
Track ER+, HER2-, Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.